SCHEMBL31379004

SCHEMBL31379004

COC(=O)c1ccc2c(c1)CCCC(c1ccc(Cl)cc1Cl)C2=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A3 Q01959 2/20 0.42
ALDH1A1 P00352 4/20 0.41
KDM4E B2RXH2 1/20 0.41
GAA P10253 1/20 0.41
HPGD P15428 1/20 0.41
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TP53 P04637 2/20 0.40
ATM Q13315 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
SLC6A2 P23975 1/20 0.40
SLC6A4 P31645 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
SRD5A1 P18405 1/20 0.39
SRD5A2 P31213 1/20 0.39
MAPT P10636 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23551037 1.00 SLC6A3 (0.42) SLC6A3ALDH1A1KDM4EGAAHPGD
SCHEMBL23528113 1.00 SLC6A3 (0.42) SLC6A3ALDH1A1KDM4EGAAHPGD
SCHEMBL29600453 0.94 SLC6A3 (0.44) SLC6A3ALDH1A1KDM4EGAAHPGD
SCHEMBL30548823 0.94 SLC6A3 (0.44) SLC6A3ALDH1A1KDM4EGAAHPGD
SCHEMBL24357853 0.94 SLC6A3 (0.44) SLC6A3ALDH1A1KDM4EGAAHPGD
SCHEMBL24429131 0.91 SLC6A2 (0.39) SLC6A3ALDH1A1TP53ATMSMN1; SMN2
SCHEMBL19230575 0.84 SLC6A2 (0.41) SLC6A3ALDH1A1ATMSMN1; SMN2SLC6A2
SCHEMBL26187133 0.82 CYP24A1 (0.42) ALDH1A1
SCHEMBL26187077 0.82 MAOA (0.46) GAATP53
SCHEMBL24357639 0.81 MAPK14 (0.48) ALDH1A1TP53ATMSMN1; SMN2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250042849-A1 Process for the Preparation of Methyl 6-(2,4-Dichlorophenyl)-5-[4-[(3S)-1-(3-Fluoropropyl)Pyrrolidin-3-yl]Oxyphenyl]-8,9-Dihydro-7H-Benzo[7]Annulene-2-Carboxylate SANOFI (FR) 2025-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250042849-A1 Process for the Preparation of Methyl 6-(2,4-Dichlorophenyl)-5-[4-[(3S)-1-(3-Fluoropropyl)Pyrrolidin-3-yl]Oxyphenyl]-8,9-Dihydro-7H-Benzo[7]Annulene-2-Carboxylate ALG8, LIG3, UGT2B7 SLC6A3 3310/4885ALDH1A1 325/4885KDM4E 152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.